Chapter 29: Pain Management in Patients with Cancer

Chapter 29: Pain Management in Patients with Cancer

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

1. A nurse is acting as a preceptor for a new nurse on the oncology unit. To evaluate the new nurse’s understanding of pain, the nurse asks, “Which statement is correct regarding the differences between nociceptive and neuropathic pain?”

a.	The two types of pain result from injury to nerves.
b.	The two types of pain respond differently to analgesic drugs.
c.	Somatic pain is a common subtype of neuropathic pain.
d.	Neuropathic pain is more common than nociceptive pain in cancer patients.

 

 

ANS:   B

These two forms of pain respond differently to analgesic drugs.

Nociceptive pain results from injury to tissue, whereas neuropathic pain results from injury to peripheral nerves.

Somatic pain is not a common subtype of neuropathic pain, but rather nociceptive pain.

Among cancer patients, nociceptive pain is more common than neuropathic pain.

 

DIF:    Cognitive Level: Analysis                  REF:    p. 287

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Physiological Adaptation

 

2. A nurse is caring for a patient undergoing chemotherapy. A patient asks for ibuprofen (Motrin) and states, “I didn’t bring mine with me. I usually take them about four times a day. The nurse should notify the prescriber and anticipate an order for a(n)

a.	serum creatinine level.
b.	platelet count.
c.	salicylate level.
d.	absolute neutrophil count.

 

 

ANS:   B

For patients undergoing chemotherapy, inhibition of platelet aggregation by nonsteroidal anti-inflammatory drugs is a serious concern, because many anticancer drugs suppress bone marrow function and reduce platelet production. Thrombocytopenia may result, putting the patient at risk for bleeding.

A serum creatinine level is not indicated, because ibuprofen is not a nephrotoxic drug.

A salicylate level would be indicated if the patient were taking aspirin, not ibuprofen.

An absolute neutrophil count is not indicated in a patient taking ibuprofen.

 

DIF:    Cognitive Level: Application             REF:    p. 292

TOP:    Nursing Process: Planning

MSC:   NCLEX Client Needs Category: Physiological Integrity: Reduction of Risk Potential

 

3. A patient with cancer has been undergoing chemotherapy and also has risk factors associated with thrombocytopenia. The patient rates her pain as a 5 on a scale of 0 to 10, with 10 being the greatest pain. Which medication would the nurse anticipate being ordered for this patient?

a.	Ibuprofen (Motrin)
b.	Celecoxib (Celebrex)
c.	Acetylsalicylic acid (aspirin)
d.	Choline salicylate (Arthropan)

 

 

ANS:   D

Choline salicylate is indicated for moderate pain; it does not inhibit platelet aggregation and therefore is safe for patients with thrombocytopenia.

Motrin inhibits platelet aggregation and should not be used in patients with thrombocytopenia.

Acetylsalicylic acid should not be used in patients with thrombocytopenia.

Celebrex is not indicated, because it poses a risk of thrombotic events.

 

DIF:    Cognitive Level: Application             REF:    p. 292

TOP:    Nursing Process: Planning

MSC:   NCLEX Client Needs Category: Physiological Integrity: Reduction of Risk Potential